
Journal of labelled compounds and radiopharmaceuticals p. 363 - 376 (1998)
Update date:2022-08-03
Topics:
Waterhouse, Rikki N.
Gotsick, J. Timothy
Kabalka, George W.
Goodman, Mark M.
O'Brien
[123I]-8-[4-[2-(5-Iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3,8- triazaspiro[4.5]-decan-4-one (1) has been synthesized as a potential ligand for dopamine D2 receptors. This new compound proved to be moderate in lipophilicity (log
View MoreShanghai Maxchemco Chemical Industry Co., Ltd.
Contact:(86)21-51079223
Address:No.1305-8, B241, the Ecust Park, Huajing Road, Xuhui District, Shanghai
Changzhou Sunlight Pharmaceutical Co., Ltd.
Contact:+86-519-83131668;83139028;83138042;83137041
Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Chemical Technology Co.,LTD(expird)
Contact:
Address:
Jining tiansheng chemical co.,ltd.
Contact:+86-537-5158722
Address:ROOM 1011, BLOCK B, CUIDU INTERNATIOAL BUSINESS CENTER, JINING CITY, CHINA
Guangzhou Probig Fine Chemical Co., Ltd.
Contact:020-86297874
Address:No.2, 1/F, No.20, Hetai Road,Hebian Village, Baiyun District,Guangzhou,China
Doi:10.1016/S0040-4020(01)96351-3
(1968)Doi:10.1002/1521-3765(20001215)6:24<4558::AID-CHEM4558>3.0.CO;2-6
(2000)Doi:10.1002/hlca.19840670720
(1984)Doi:10.1016/S0960-894X(98)00194-2
(1998)Doi:10.1016/S0040-4020(98)00467-0
(1998)Doi:10.1055/s-1998-1819
(1998)